A very valuable resource joined Corteria Pharmaceuticals: we are very proud to announce that Francesca Lawson is our new Chief Medical Officer. 

Francesca is a physician with 30+ years’ experience in drug development encompassing phase 1 through phase 3 registrational trials and life cycle management. Her specialized expertise is in cardio-metabolic diseases. She joined Corteria from Applied Therapeutics, a clinical-stage biotechnology company, where, as the Head of Development and later VP, Clinical and Regulatory Strategy, she was responsible for the development of novel drug candidates for diabetic cardiomyopathy and rare diseases. Prior to Applied Therapeutics, she was the Associate VP and Head of Cardiovascular Outcome Trials in Diabetes at Sanofi. Francesca received her MD degree (magna cum laude) from La Sapienza University of Rome, Italy and an advanced degree in Clinical Pharmacology (magna cum laude) from the Catholic University of Rome, Italy.